<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30388485</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1877-783X</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>57</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>27</Day>                    </PubDate>                </JournalIssue>                <Title>Cancer epidemiology</Title>                <ISOAbbreviation>Cancer Epidemiol</ISOAbbreviation>            </Journal>            <ArticleTitle>A historical cohort study on glycemic-control and cancer-risk among patients with diabetes.</ArticleTitle>            <Pagination>                <MedlinePgn>104-109</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1877-7821(18)30109-7</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canep.2018.10.010</ELocationID>            <Abstract>                <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This population-based historical cohort study examined whether poor glycemic-control (i.e., high glucose and HbA1c blood levels) in patients with diabetes is associated with cancer-risk.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">From a large healthcare database, patients aged 21-89 years, diagnosed with diabetes before January 2002 (prevalent) or during 2002-2010 (incident), were followed for cancer during 2004-2012 (excluding cancers diagnosed within the first 2 years since diabetes diagnosis). Risks of selected cancers (all-sites, colon, breast, lung, prostate, pancreas and liver) were estimated according to glycemic-control in a Cox regression model with time-dependent covariates, adjusted for age, sex, ethnic origin, socioeconomic status, smoking and parity. Missing glucose or HbA1c values were imputed.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 440,000 patients included in our analysis, cancer was detected more than 2 years after diabetes diagnosis in 26,887 patients (6%) during the follow-up period. Associations of poor glycemic-control with all-sites cancer and most specific cancers were either null or only weak (hazard ratios (HRs) for a 1% HbA1c or a 30 mg/dl glucose increase between 0.94 and 1.09). Exceptions were pancreatic cancer, for which there was a strong positive association (HRs: 1.26-1.51), and prostate cancer, for which there was a moderate negative association (HRs: 0.85-0.96).</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall, poor glycemic-control appears to be only weakly associated with cancer-risk, if at all. A substantial part of the positive association with pancreatic cancer is attributable to reverse causation, with the cancer causing poorer glycemic-control prior to its diagnosis. The negative association with prostate cancer may be related to lower PSA levels in those with poor control.</AbstractText>                <CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Dankner</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel; Patient Oriented Research, The Feinstein Institute for Medical Research, Manhasset, North Shore, New York, United States. Electronic address: racheld@gertner.health.gov.il.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Boker</LastName>                    <ForeName>L Keinan</ForeName>                    <Initials>LK</Initials>                    <AffiliationInfo>                        <Affiliation>The Israel Center for Disease Control, Israel Ministry of Health, Israel; School of Public Health, Faculty of Social Welfare and Health Sciences, Haifa University, Haifa, Israel.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Boffetta</LastName>                    <ForeName>P</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York NY, United States.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Balicer</LastName>                    <ForeName>R D</ForeName>                    <Initials>RD</Initials>                    <AffiliationInfo>                        <Affiliation>Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel; Public Health Department, Ben-Gurion University of the Negev, Beer Sheva, Israel.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Murad</LastName>                    <ForeName>H</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Unit for Biostatistics, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Berlin</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel; Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Olmer</LastName>                    <ForeName>L</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Unit for Biostatistics, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Agai</LastName>                    <ForeName>N</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Freedman</LastName>                    <ForeName>L S</ForeName>                    <Initials>LS</Initials>                    <AffiliationInfo>                        <Affiliation>Sackler Faculty of Medicine, Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel; Unit for Biostatistics, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Cancer Epidemiol</MedlineTA>            <NlmUniqueID>101508793</NlmUniqueID>            <ISSNLinking>1877-7821</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Blood glucose control</Keyword>            <Keyword MajorTopicYN="N">Cancer</Keyword>            <Keyword MajorTopicYN="N">Cohort</Keyword>            <Keyword MajorTopicYN="N">Glycemic-control</Keyword>            <Keyword MajorTopicYN="N">HbA1c</Keyword>            <Keyword MajorTopicYN="N">Missing data</Keyword>            <Keyword MajorTopicYN="N">Multiple imputation</Keyword>            <Keyword MajorTopicYN="N">Risk</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>10</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30388485</ArticleId>            <ArticleId IdType="pii">S1877-7821(18)30109-7</ArticleId>            <ArticleId IdType="doi">10.1016/j.canep.2018.10.010</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>